0655 GMT - Chularat Hospital faces a revenue hit in 2026 from Middle East tensions, CGS International's Kasem Prunratanamala says in a research report. At an analyst meeting, management expressed caution over its outlook owing to these tensions, noting potential spillover to Thailand's economy and domestic patient traffic. The Thai hospital's inpatient revenues are likely to fall 5% this year, the analyst estimates. The brokerage cuts its 2026 revenue growth forecast for the hospital to 1% from 4%, and lowers the stock's target price to THB1.95 from THB2.04. However, CGS International maintains the stock's add rating, supported by expected earnings recovery for the hospital in 2027-2028. Shares are 1.4% higher at THB1.45. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
March 20, 2026 02:55 ET (06:55 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.

